Skip to main navigation
Skip to search
Skip to main content
Ariel University Home
Help & FAQ
Link opens in a new tab
English
עברית
العربية
Search content at Ariel University
Home
Profiles
Research units
Equipment
Research output
Prizes
Activities
Press/Media
Gastric-Outlet Obstruction Induced by Prostaglandin Therapy in Neonates
Nathan Peled
, Ovdi Dagan
, Paul Babyn
, Meredith M. Silver
, Geoffrey Barker
, Jonathan Hellmann
, Dennis Scolnik
, Gideon Koren
Research output
:
Contribution to journal
›
Article
›
peer-review
89
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Gastric-Outlet Obstruction Induced by Prostaglandin Therapy in Neonates'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Neonate
100%
Prostaglandins
100%
Gastric Outlet Obstruction
100%
Prostaglandin E1 (PGE1)
57%
Hyperplasia
35%
Gastric Obstruction
35%
Ductus Arteriosus
14%
Clinical Signs
14%
Patency
14%
Congenital Heart Disease
14%
Pathological Evidence
14%
Radiologic
14%
Healthy Neonates
14%
Central Nervous System
7%
Infusion Rate
7%
High Probability
7%
Low Risk
7%
Recommended Dose
7%
Cumulative Dose
7%
Pathological Examination
7%
Success Probability
7%
Pulmonary Hypertension
7%
Persistent Fetal Circulation
7%
Radiological Assessment
7%
Mucosal Hyperplasia
7%
Mucosal Thickening
7%
Medicine and Dentistry
Neonate
100%
Prostaglandin
100%
Pylorus Stenosis
100%
Prostaglandin E1
50%
Hyperplasia
37%
Stomach Obstruction
31%
Ductus Arteriosus
12%
Infusion
12%
Body Weight
12%
Persistent Truncus Arteriosus
12%
Central Nervous System
6%
Infusion Rate
6%
Recommended Drug Dose
6%
Persistent Fetal Circulation
6%
Pulmonary Hypertension
6%
Cardiovascular System
6%
Veterinary Science and Veterinary Medicine
Prostaglandin
100%
Prostaglandin E1
100%
Gastric Outlet Obstruction
100%
Hyperplasia
75%
Clinical Signs
25%
Diseases
25%
Ductus Arteriosus
25%
Fetal Circulation
12%
Central Nervous System
12%
Pulmonary Hypertension
12%
Pharmacology, Toxicology and Pharmaceutical Science
Prostaglandin E1
100%
Pylorus Stenosis
100%
Prostaglandin
100%
Hyperplasia
75%
Stomach Obstruction
62%
Congenital Heart Disease
25%
Persistent Pulmonary Hypertension
12%
Pulmonary Hypertension
12%